Gainers
- Aridis Pharmaceuticals ARDS shares increased by 89.5% to $0.5 during Monday's after-market session. At the close, Aridis Pharmaceuticals's trading volume reached 8.1 million shares. This is 212.0% of its average volume over the last 100 days. The company's market cap stands at $18.0 million.
- Dare Bioscience DARE stock moved upwards by 7.72% to $0.92. The company's market cap stands at $79.3 million.
- Karyopharm Therapeutics KPTI stock rose 6.53% to $1.63. Trading volume for this security closed at 514.4K, accounting for 17.8% of its average full-day volume over the last 100 days. The company's market cap stands at $185.8 million.
- Cue Health HLTH stock rose 5.45% to $0.45. The company's market cap stands at $67.9 million.
- Cardio Diagnostics Hldgs CDIO stock rose 5.17% to $1.22. The company's market cap stands at $12.1 million.
- Petros Pharma PTPI shares rose 4.98% to $3.58. The company's market cap stands at $7.5 million.
Losers
- 9 Meters Biopharma NMTR shares fell 60.0% to $0.25 during Monday's after-market session. 9 Meters Biopharma's trading volume hit 886.9K shares by close, accounting for 1142.9% of its average volume over the last 100 days. The market value of their outstanding shares is at $3.6 million.
- Masimo MASI stock fell 24.92% to $110.5. Masimo's trading volume hit 84.8K shares by close, accounting for 18.1% of its average volume over the last 100 days. The company's market cap stands at $5.8 billion.
- CEL-SCI CVM shares fell 21.33% to $2.25. At the close, CEL-SCI's trading volume reached 388.8K shares. This is 210.0% of its average volume over the last 100 days. The market value of their outstanding shares is at $100.6 million.
- EUDA Health Holdings EUDA stock fell 16.41% to $0.51. This security traded at a volume of 1.1 million shares come close, making up 248.7% of its average volume over the last 100 days. The market value of their outstanding shares is at $12.6 million.
- First Wave BioPharma FWBI shares decreased by 16.08% to $0.68. This security traded at a volume of 153.5K shares come close, making up 8.9% of its average volume over the last 100 days. The market value of their outstanding shares is at $2.8 million.
- Acumen Pharmaceuticals ABOS stock declined by 9.68% to $8.78. Acumen Pharmaceuticals's trading volume hit 12.7 million shares by close, accounting for 4221.5% of its average volume over the last 100 days. The company's market cap stands at $360.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in